(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|
Turnover | --1.65B | -14.57%2.68B | 12.34%3.13B | 74.49%2.79B | -5.49%1.6B | --1.69B |
Operating income | 1.65B | -14.57%2.68B | 12.34%3.13B | 74.49%2.79B | -5.49%1.6B | 1.69B |
Cost of sales | ---1.46B | 3.58%-2.35B | -13.22%-2.43B | -83.04%-2.15B | 18.22%-1.17B | ---1.44B |
Operating expenses | -1.46B | 3.58%-2.35B | -13.22%-2.43B | -83.04%-2.15B | 18.22%-1.17B | -1.44B |
Gross profit | 186.68M | -52.84%329.77M | 9.41%699.28M | 50.80%639.12M | 66.30%423.82M | 254.85M |
Selling expenses | ---13.41M | 13.71%-20.72M | -21.14%-24.01M | -16.08%-19.82M | 1.00%-17.08M | ---17.25M |
Administrative expenses | ---60.21M | 18.10%-95.42M | -15.97%-116.5M | -63.85%-100.46M | -3.83%-61.31M | ---59.05M |
Research and development expenses | ---58.86M | 24.84%-99.96M | -20.00%-133M | -39.63%-110.83M | -8.13%-79.37M | ---73.41M |
Impairment and provision | ---440K | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---440K | ---- | ---- | ---- | ---- | ---- |
Operating interest expense | ---- | -4.04%-32.28M | 8.92%-31.03M | -18.61%-34.07M | 5.46%-28.72M | ---30.38M |
Special items of operating profit | --23.46M | -28.96%20.71M | 69.98%29.15M | -25.39%17.15M | -10.12%22.99M | --25.57M |
Operating profit | 77.22M | -75.91%102.1M | 8.39%423.89M | 50.23%391.1M | 159.44%260.32M | 100.34M |
Financing cost | ---21.13M | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | --3.48M | -62.23%4.47M | 40.14%11.84M | 34.17%8.45M | 37.18%6.3M | --4.59M |
Share of profit from joint venture company | --3.86M | -47.12%-11.83M | -33.84%-8.04M | -109.41%-6.01M | -1,775.82%-2.87M | ---153K |
Earning before tax | 63.42M | -77.85%94.74M | 8.68%427.69M | 49.21%393.54M | 151.72%263.75M | 104.78M |
Tax | ---15.38M | 74.96%-21.84M | -3.34%-87.22M | -48.65%-84.4M | -156.17%-56.78M | ---22.16M |
After-tax profit from continuing operations | 48.05M | -78.59%72.9M | 10.14%340.47M | 49.36%309.14M | 150.53%206.97M | 82.62M |
Earning after tax | 48.05M | -78.59%72.9M | 10.14%340.47M | 49.36%309.14M | 150.53%206.97M | 82.62M |
Profit attributable to shareholders | 48.05M | -78.59%72.9M | 10.14%340.47M | 49.36%309.14M | 150.53%206.97M | 82.62M |
Basic earnings per share | 0.63 | -78.63%0.97 | 10.19%4.54 | 49.28%4.12 | 1,523.53%2.76 | 0.17 |
Diluted earnings per share | 0.63 | -78.63%0.97 | 10.19%4.54 | 49.28%4.12 | 1,523.53%2.76 | 0.17 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data